Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 183.00
-0.50 (-0.27%)
Dec 17, 2025, 9:20 AM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 14.36 billion as of December 16, 2025. Its market cap has decreased by -4.09% in one year.
Market Cap
14.36B
Enterprise Value
11.52B
Revenue
6.89B
Ranking
n/a
PE Ratio
5.95
Stock Price
183.00
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 14.36B, an increase of 33,526.22%. That is a compound annual growth rate of 23.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 14.62B | -1.75% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | 10.91B | 96.88% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.41T |
| Coloplast | 126.39B |
| Genmab | 124.00B |
| ALK-Abelló | 49.63B |
| Demant | 45.20B |
| H. Lundbeck | 41.24B |
| Zealand Pharma | 34.18B |
| Ambu A/S | 23.26B |